Other Stories

Samsung BioLogics says no decision has been made on producing Moderna's COVID-19 vaccine Updated: 2021-05-14 15:03:37 KST

Pharmaceutical company Samsung BioLogics says no decision has been made yet on whether it will manufacture Moderna's COVID-19 vaccine in South Korea.
The company said on Friday, that it will make an official announcement regarding this matter within one month.
This contrasts with the company's firm denial earlier this week, regarding rumors that it was working to produce vaccines with Pfizer.
Industry watchers are predicting that Moderna will sign a contract manufacturing deal with a Korean pharmaceutical company, as it is pushing to set up a subsidiary in South Korea.
Moderna's vaccine has not been approved in Korea yet, but the final approval from the drug ministry is set to be made next Friday.
Reporter : jhee@arirang.com
KOGL : Korea Open Government License
본 저작물 중 본문에 해당하는 뉴스 스크립트(텍스트)는 공공누리 제1유형-출처표시 조건에 따라 이용할 수 있습니다.